Copertina

Do antithrombotic drugs have a role in migraine prevention? A systematic review

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Federico De Santis, Matteo Foschi, Michele Romoli, Vincenzo Mastrangelo, Chiara Rosignoli, Agnese Onofri, Simona Sacco, Raffaele Ornello
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: Insights from a cross‐sectional study
di: Raffaele Ornello, et al.
Pubblicazione: (2025)

A year of milestones in headache: Highlights from Cephalalgia 2025
di: Simona Sacco
Pubblicazione: (2026)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
di: Jonathan R. Treadwell, et al.
Pubblicazione: (2025)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
di: Irene Patniyot, et al.
Pubblicazione: (2024)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
di: Hedda S. Riise, et al.
Pubblicazione: (2026)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
di: Chia‐Chun Chiang, et al.
Pubblicazione: (2024)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
di: Lawrence C. Newman, et al.
Pubblicazione: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
di: Kara S. Graves, et al.
Pubblicazione: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
di: Raghavan Gopalakrishnan, et al.
Pubblicazione: (2024)

Prevalence and burden of migraine in the United States: A systematic review
di: Fred Cohen, et al.
Pubblicazione: (2024)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
di: Jessica Ailani, et al.
Pubblicazione: (2026)

The association between posttraumatic stress disorder and migraine: A systematic review
di: Lucie Nitsche, et al.
Pubblicazione: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
di: Jessica Ailani, et al.
Pubblicazione: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
di: Joanna K. Bougie, et al.
Pubblicazione: (2024)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
di: Julia Peris‐Subiza, et al.
Pubblicazione: (2025)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
di: Geneviève Tourigny‐Ruel, et al.
Pubblicazione: (2026)

A novel de novo AP2M1 variant in a patient with attention‐deficit/hyperactivity disorder, oppositional defiant disorder, and unexpected hemiplegic migraine
di: Giuseppe D. Mangano, et al.
Pubblicazione: (2025)

The “central vein sign” to differentiate multiple sclerosis from migraine
di: Giulia Silvestri, et al.
Pubblicazione: (2025)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
di: Emmanuelle A. D. Schindler, et al.
Pubblicazione: (2025)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
di: Dawn C. Buse, et al.
Pubblicazione: (2024)

The effect of vestibular rehabilitation in the management of vestibular migraine in adults: A systematic review and meta‐analysis
di: Jad El Ahdab, et al.
Pubblicazione: (2025)

Driving evidence to practice for management of migraine in the emergency department: A systematic approach to guideline implementation
di: Jennifer Robblee, et al.
Pubblicazione: (2026)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
di: David Kudrow, et al.
Pubblicazione: (2025)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies
di: Guoliang Zhu, et al.
Pubblicazione: (2024)

Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis
di: Pablo D. Suarez‐Barcena, et al.
Pubblicazione: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
di: Rebecca Lindsay, et al.
Pubblicazione: (2024)

Reliability, validity, and responsiveness of the Arabic version of HIT ‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study
di: Mona Hussein, et al.
Pubblicazione: (2024)

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
di: Gabriel Paiva da Silva Lima, et al.
Pubblicazione: (2025)

The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis
di: Scott W. Kirkland, et al.
Pubblicazione: (2024)

Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update
di: Andrew C. Charles, et al.
Pubblicazione: (2024)

Evaluating associations of migraine‐related vertigo
di: Nazia Karsan, et al.
Pubblicazione: (2025)

Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis
di: Luana Miyahira Makita, et al.
Pubblicazione: (2025)

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIUMPH study
di: Shivang Joshi, et al.
Pubblicazione: (2026)

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
di: David W. Dodick, et al.
Pubblicazione: (2025)

Afterimage duration differs for migraine with or without aura
di: Florian Rimmele, et al.
Pubblicazione: (2025)